2,008 followers
RT @ncgds: New publication available online: Ribociclib with an Aromatase Inhibitor for Previously Untreated, HR-Positive, HER2-Negative,…
RT @ncgds: New publication available online: Ribociclib with an Aromatase Inhibitor for Previously Untreated, HR-Positive, HER2-Negative,…
#HealthEconJA Ribociclib with an Aromatase Inhibitor for Previously Untreated, HR-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal https://t.co/Gmf4wMSWfA